Introduction {#sec1}
============

Infertility is a worldwide health problem, affecting approximately 15% of couples with child-bearing age, and male factor has been deemed to 50% causes for infertility \[[@B1]\]. The main cause of male infertility is sperm quality loss displaying azoospermia, oligozoospermia, asthenozoospermia and teratospermia. In these cases, asthenozoospermia is one of the major causes of human male infertility, characterized by reduced forward motility of spermatozoa (grade A + B sperm motility \< 50% or A \< 25%), which prevents the sperm from moving to the egg and penetrating it, eventually leading to infertility \[[@B2]\]. However, the cause and pathogenesis of asthenozoospermia are not completely understood.

Exosomes are nanosized extracellular vesicles (40--180 nm) that can be released by almost all types of cells and exist stably in various biological fluids (e.g. blood, urine, saliva, seminal and follicular) \[[@B3]\]. The importance of exosomes lies in their role in intercellular communication by transmitting bioactive molecules, including proteins, DNA, mRNAs and non-coding RNAs. Exosomes could transfer information to recipient cells and thereby influencing the cell functions \[[@B4]\]. These unique properties make exosomes a potential candidate as reliable biomarkers. The recent studies have shown that exosomes are secreted along the male reproductive tract and are thought to be involved in spermatozoa maturation and function \[[@B5],[@B6]\]. Murdica et al. \[[@B7]\] have reported that seminal plasma of men with severe asthenozoospermia contains exosomes that affect spermatozoa motility, and could promptsperm capacitation through an increased induction of tyrosine phosphorylation, therefore, inducing the acrosome reaction. Meanwhile, Murdica et al. \[[@B8]\] revealed the negative modulator of sperm function glycodelin as over-represented in semen exosomes isolated from asthenozoospermic patients by proteomics analysis.

Long noncoding RNAs (lncRNAs) are a group of nonprotein-coding RNAs with a length longer than 200 nucleotides that distributed in the genome broadly \[[@B9]\]. Accumulating evidence suggests that lncRNAs regulate gene expression in the form of RNA in epigenetic regulation, regulation of transcription and post-transcriptional regulation levels \[[@B10]\]. The regulatory and structural functions of lncRNAs have been reported to play pivotal roles in a broad scope of biological processes, and disorderly regulation of lncRNAs leads to diverse human diseases \[[@B11]\]. Recent discovery of lncRNAs as critical regulators in normal and disease development provides new clues for delineating the molecular regulation in male germ-cell development \[[@B12]\]. Necsulea et al. \[[@B13]\] performed a large-scale evolutionary study of lncRNA repertoires and expression patterns, in 11 tetrapod species and found the potential functions for lncRNAs in spermatogenesis processes. Wen et al. \[[@B14]\] revealed that rapidly evolving testis-specific lncRNAs play critical roles in late Drosophila spermatogenesis. Wichman et al. \[[@B15]\] found that dysregulation of specific lncRNAs led to sperm counts or infertility reduced in mice. Recently, Zhang et al. \[[@B16]\] explored the expression profiles and characteristics of human lncRNAs in normal and asthenozoospermia sperm indicating an association between lncRNAs expression and sperm motility. However, the expression and characteristics of lncRNAs in seminal plasma exosomes of normal and asthenozoospermia have not been addressed.

Therefore, to investigate the intricate regulatory network associated with asthenozoospermia, we performed RNA-sequencing and analyzed the differentially expressed genes (DEGs), differentially expressed lncRNAs (DElncRNAs) and differentially expressed messenger RNAs (DEmRNAs) and new lncRNAs between normal and asthenozoospermia groups with bioinformatics in the present study. Subsequently, we predicted the biological function of the DEGs using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and DO (Disease Ontology) enrichment analyses. In addition, we constructed co-expression networks of the lncRNA--miRNA--mRNA with specific bioinformatics approaches to search the hub lncRNAs in the development of asthenozoospermia. To confirm sequencing results with five of the identified DElncRNAs, we performed quantitative reverse-transcription polymerase chain reaction (qRT-PCR) between normal (*n*=20) and asthenozoospermia (*n*=20) groups.

Materials and methods {#sec2}
=====================

Sample collection {#sec2-1}
-----------------

We selected 25 male sterility diagnosed with asthenozoospermia and 25 male normal healthy individuals at the First Affiliated Hospital of Hainan Medical College. The semen samples (8 ml) were collected by masturbation into a sterile container after 3--7 days of abstinence. We used a sperm quality analyzer to assess the semen basic parameters, including morphology, concentration, motility, viability and counts of spermatozoa. According to the World Health Organization (WHO, 2010, Fifth Edition) standards on the diagnostic criteria of asthenozoospermia, the rapid forward progressive motile sperm (grade A \<25%) and total progressive motile sperm (grades A + B \<50%) in fresh ejaculation \[[@B17]\]. The semen samples were considered normal with the following parameters: sperm concentration ≥ 15 × 10^6^/ml, semen volumes ≥ 1.5 ml, pH ≥ 7.2, progressive motility (PR) ≥ 32%, PR + Non-progressive motility (NP) ≥ 40%. The age range of asthenozoospermia patients and normal healthy controls was 24--48 years old. Control subjects with underlying diseases or abnormal sperm parameters were excluded from the study. All the participants are ethnic Han Chinese with no genetic relationship. Patients with congenital or hereditary disease that cause gonadal dysplasia were excluded from the study. Patients with genitourinary infections, endocrine diseases such as diabetes and hyperthyroidism, severe heart, liver, kidney or other functional abnormalities were also excluded.

Isolation and identification of exosomes {#sec2-2}
----------------------------------------

The semen samples were allowed to liquefy for 30 min at 37°C, 5% CO~2~ incubator. Then, semen samples were centrifuged at 1000 × ***g*** for 10 min to separate seminal plasma containing exosomes. Subsequently, the each seminal plasma sample was transferred to a 15 ml centrifuge tube, and was centrifuged at 300 × ***g*** for 10 min, 2000 × ***g*** for 20 min at 4°C, respectively. We discard the precipitate and remove the cells. Then, supernatants were in turn centrifuged at 10,000 × ***g*** for 30 min. We discard the precipitate and remove subcellular components. The remaining supernatants were centrifuged at 10,000 × ***g*** for 60 min. We discard the supernatant, and the resulting precipitate is the seminal plasma exosomes. Exosome-containing pellets were re-suspended with 30 ml PBS, followed by centrifugation at 10,000 × ***g*** for 60min. The Precipitator-purified exosomes were suspended with 1 ml PBS. Then, samples were loaded separately into the eppendorf tube and stored in a −80°C refrigerator for future use. The morphological characteristics were observed by transmission electron microscopy (H-7650, Hitachi Limited, Japan) according to the manufacturer's instructions.

Western blot {#sec2-3}
------------

Western blot was used to detect exosome-specific antigen molecules CD63 and CD81. We used the reducing Laemmli buffer to dissolve the seminal plasma exosomes (5 μg) and boiled for 5 min at 95°C. Proteins were resolved in a 10% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), followed by being transferred to a PVDF membrane. The membranes were blocked in 5% skimmed milk in PBS containing 0.5% Tween-20 at room temperature for 1 h prior to being probed with the anti-CD63 (1:20,000, \#556019; BD Pharmingen), anti-CD81 (1:5,000, \#555675; BD Pharmingen) at 4°C overnight. After washing with T-TBS, membranes followed by being incubated with the appropriate horseradish peroxidase-labeled secondary antibody (goat anti-mouse (1: 10,000) or anti-rabbit (1: 2000) immunoglobulin G) for 45 min. The enhanced chemiluminescence (ECL) reagent (Advansta, Menlo Park, CA, U.S.A.) was used to detect the positive immunoreactive bands.

RNA isolation, library preparation and sequencing analysis {#sec2-4}
----------------------------------------------------------

LncRNA-sequencing was performed by the Bioacme Biotechnology Co., Ltd. (Wuhan, China). Briefly, total RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.) from the exosomes of asthenozoospermia patients and normal healthy controls. Total RNA was quantified using a spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific, Waltham, MA, U.S.A.) according to manufacturers' instructions. We used the Agilent 2100 system and an RNA Nano 6000 Assay kit (Agilent Technologies, Santa Clara, CA, U.S.A.) to assess RNA integrity. The ribosomal RNA (rRNA) was removed using Ribo-Zero rRNA removal beads (Illumina, Inc., San Diego, CA, U.S.A.), fragmentation (the average segment length is approximately 200 nt), to enable accurate lncRNA analysis. The extracted total RNA was reverse transcribed into single-stranded complementary DNA (cDNA), then synthesized into a double-stranded cDNA, terminal repair, 3′ terminal addition, ligation, and addition of primers, PCR amplification and purification, and quality inspection of the library. The generated libraries were sequenced on an Illumina HiSeq 3000 (Illumina Inc, San Diego, CA) with PE150 according to the manufacturer's protocol. Subsequently, data analyses were performed *in silico*.

Data processing and quality control {#sec2-5}
-----------------------------------

The htseq-count software was used to calculate the gene expression, and the alignment of the mass below 10 in the bam file were excluded, and the obtained gene expression count matrix was used as the downstream analysis data. The raw count data were filtered based on the filter criteria that the counts per million (CPM) was greater than 1. The filtered data were standardized using the R software DESeq2 package. All samples were quality controlled based on standardized data to eliminate outlier samples. We used principal component analysis (PCA) to evaluate inter-sample relationships.

DEGs analysis {#sec2-6}
-------------

We used the R software DESeq2 package to analyze the differences in gene's expression levels between the asthenozoospermia group and the normal control group. Genes with *P* value ≤ 0.05 and the log~2~ fold change (FC) absolute value ≥ 1 were considered differentially expressed.

Enrichment analysis {#sec2-7}
-------------------

The GO and KEGG and DO enrichment analyses were applied to determine the functional roles and related pathways of DEGs using the clusterProfiler package in R \[[@B18]\]. The GO analysis (<http://www.geneontology.org>) is a functional analysis associating DEGs with the GO biological process (BP), cellular component (CC) and molecular function (MF) categories \[[@B19]\]. We make the GO function annotations for DEGs and explore the biological significance of each gene. The KEGG database (<http://www.genome.jp/kegg/>) includes biochemical reactions, signaling pathways, metabolic pathways and biological processes. KEGG pathway analysis to identify signaling pathways associated with DEGs. The DO (<http://disease-ontology.org>) analysis was used for the identification of DEG-disease associations \[[@B20]\]. *P* values \< 0.05 were considered significantly enriched by the DEGs.

Association analysis lncRNA and mRNA expression {#sec2-8}
-----------------------------------------------

DElncRNAs and DEmRNA were identified through fold change filtering. The correlation between the expression levels of each DElncRNAs and DEmRNAs was calculated using the Pearson's correlation test. The correlation coefficient was greater than 0.8 and *P* value less than 0.05 were defined as the DElncRNA--DEmRNA pairs coexpressed. In addition, we performed GO and KEGG enrichment analyses of DElncRNA co-expressing differential genes.

Target gene prediction {#sec2-9}
----------------------

To identify the targeted genes of DElncRNAs, we used the bedtools software to search the nearby coding genes of DElncRNAs and excluded the gene with a distance of more than 100 kilobases upstream or downstream of DElncRNAs. Simultaneously, we took genes that intersect with the co-expressed DEGs with DElncRNAs. These obtained DEGs were defined as the cis-regulated target genes.

lncRNA--miRNA--mRNA regulatory networks {#sec2-10}
---------------------------------------

We used hypergeometric distribution to test whether a DEG target microRNA (miRNA) set was enriched on lncRNA target miRNA set, and *P* value less than 0.05 was considered statistically significant. Accordingly, a co-expression regulatory network representing the possible lncRNA--miRNA--mRNA interaction between key lncRNA and target mRNA/miRNA was established by Cytoscape software (version 3.7.1).

New lncRNAs prediction {#sec2-11}
----------------------

Each sample was assembled separately using Stringtie software, then all sample transcripts were combined using the Stringtie merges command, and then the combined results were compared with known gene models using gffcompare software to discover new transcript information. Moreover, new transcripts with lengths greater than 200 for coding potential identification were screened using the LGC software (<http://bigd.big.ac.cn/lgc>). Abnormal samples Z1, Z4, R2 were excluded, and we used the R software DESeq2 package for differential analysis to screen differential expression of new lncRNAs.

qRT-PCR validation of lncRNAs {#sec2-12}
-----------------------------

Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.) was used to extract RNA from the exosomes of asthenozoospermia patients (*n*=20) and normal healthy controls (*n*=20) according to the manufacturer's instructions. RNA was reverse transcribed to cDNA using the Reverse Transcription Kit (Takara Co., Ltd., Dalian, China). The quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was performed using the Applied Biosystems 7900HT system (Applied Biosystems) with an SYBR Premix Ex Taq™ kit (Takara Bio, Inc.) according to the manufacturer's instructions. The primers were designed using Primer BLAST (<https://www.ncbi.nlm.nih.gov/tools/primer-blast/>) (Supplementary Table S1) and synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). The lncRNA expression level was verified by qRT-PCR using GAPDH as the reference gene with the 2^−ΔΔCT^ method. Each sample was run as three replicates and qPCR experiments were repeated at least three times (*n*=3).

Statistical analysis {#sec2-13}
--------------------

Statistical analysis was carried out using the SPSS13.0 software (IBM Corp, Armonk, NY). The significant differences in expression levels between asthenozoospermia patients and normal healthy controls groups were tested using a two-tailed Student's *t* test. The significance of the GO terms or enrichment of pathway identifiers in the DEGs was evaluated using the Fisher's exact test. A value of *P* less than 0.05 was considered statistically significant.

Results {#sec3}
=======

The basic characteristics and sperm parameters of case and control are summarized in [Table 1](#T1){ref-type="table"}. A total of 50 subjects were recruited in the case--control study, including 25 patients (mean age ± standard deviation (SD): 32.8 ± 6.53 and 35.0 ± 6.22) and 25 controls (mean age ± SD: 32.4 ± 5.32 and 34.7 ± 5.38). There were no statistically significant differences between case and control group with regarded to age, BMI, smoking and drinking distribution (*P*\>0.05). The sperm parameters, including sperm volume, sperm density, PR, IM, and sperm activity rate are significantly different between the case group and the control group (*P*\>0.05).

###### Basic characteristics and sperm parameters of cases and controls

  Variables                   Case (*n*=5)   Control (*n*=5)   *P*       Case (*n*=20)   Control (*n*=20)   *P*
  --------------------------- -------------- ----------------- --------- --------------- ------------------ ---------
  Age                         32.8 ± 6.53    32.4 ± 5.32       0.918     35 ± 6.22       34.7 ± 5.38        0.871
  BMI                         24.8 ± 2.69    25.1 ± 3.32       0.884     25.3 ± 3.2      25.6 ± 4.15        0.816
  Smoking                                                      0.490                                        0.736
  Yes                         3 (60%)        4 (80%)                     14 (70%)        13 (65%)           
  No                          2 (40%)        1 (20%)                     6 (30%)         7 (35%)            
  Drinking                                                     1.000                                        1.000
  Yes                         4 (80%)        4 (80%)                     15 (75%)        15 (75%)           
  No                          1 (20%)        1 (20%)                     5 (25%)         5 (25%)            
  Sperm volume (ml)           3.0 ± 0.73     4.8 ± 1.28        0.024     2.8 ± 0.8       3.7 ± 1.66         0.041
  pH                          7.7 ± 0.16     7.7 ± 0.19        0.613     7.5 ± 0.47      7.7 ± 0.17         0.083
  Sperm density (×10^6^/ml)   13.9 ± 11.44   59.6 ± 16.58      0.001     13.8 ± 14       55.6 ± 13.57       \<0.001
  PR                          0.1 ± 0.05     0.5 ± 0.04        \<0.001   0.1 ± 0.07      0.6 ± 0.04         \<0.001
  IM                          0.9 ± 0.07     0.3 ± 0.13        \<0.001   0.9 ± 0.1       0.4 ± 0.02         \<0.001
  NP                          0 ± 0.04       0.1 ± 0.16        0.236     0 ± 0.05        0.1 ± 0.02         0.430
  Sperm activity rate         0.1 ± 0.07     0.6 ± 0.02        \<0.001   0.1 ± 0.1       0.6 ± 0.03         \<0.001

Abbreviations: IM, inactive sperm rate; NP, non-progressive motility; PR, progressive motility.

*P*\<0.05 was considered statistically significant.

The characterization of exosomes from human seminal plasma was shown in [Figure 1](#F1){ref-type="fig"}. The translucent electron microscope observation results showed that the vesicles derived from normal and asthenozoospermia men displayed similar shape and size, and the ranged of vesicles from 50 to 150 nm, with most of them \<100 nm in both groups ([Figure 1](#F1){ref-type="fig"}A,B). To further characterize the vesicles, we used the Western blot to detect the exosome-specific antigen molecules CD63 and CD81 ([Figure 1](#F1){ref-type="fig"}C). The analysis results indicated that all samples expressed these markers, and the total protein content has no significant differences between normal and asthenozoospermia groups.

![The Characterization of seminal plasma exosomes\
(**A**) Transmission electron microscope image of exosomes in normal. (**B**) Transmission electron microscope image of asthenozoospermia. (**C**) Western blotting demonstrating the expression of CD63, and CD81 in normal and asthenozoospermia group.](bsr-40-bsr20194041-g1){#F1}

We used the R software DESeq2 package to analyze the differences in gene\'s expression levels between asthenozoospermia and normal groups. A total of 4228 significantly DEGs, containing 2344 up-regulated DEGs and 1884 down-regulated DEGs, in asthenozoospermia group compared with normal group were obtained by \|log~2~FC\| ≥ 1 and *P*-value ≤ 0.05 (Supplementary Table S2). Top 10 significantly up-regulated and top 10 significantly down-regulated DEGs (asthenozoospermia vs. normal group) were displayed in [Table 2](#T2){ref-type="table"}. Volcano plots and heatmaps of DEGs between asthenozoospermia and normal groups were displayed in [Figure 2](#F2){ref-type="fig"}A,B.

![Differentially expressed genes between asthenozoospermia infertility and normal groups\
(**A**) Volcano plot of DEGs between asthenozoospermia infertility and normal groups. Black dots represent genes that are not significantly differentially expressed. Green and red dots indicate significant up-regulated and down-regulated genes (\|log 2 fold change\| ≥ 1.0 and *P* value ≤ 0.05), respectively. (**B**) Heatmap of DEGs between asthenozoospermia infertility and normal groups. Row and column were used to represent DEGs and samples. R: asthenozoospermia infertility; Z: normal. The color scale represented the expression levels of DEGs.](bsr-40-bsr20194041-g2){#F2}

###### The differentially expressed genes between asthenozoospermia and normal (top 10)

  No.     Up-regulated   Down-regulated                                         
  ------- -------------- ---------------- ---------- -------------- ----------- ----------
  1       *AC009965.1*   9.767628         2.61E-08   *RN7SL2*       −10.80410   2.43E-12
  2       *AL589843.2*   9.334522         4.12E-07   *HMGN1P28*     −8.382749   5.20E-08
  3       *AC004853.2*   8.941995         3.76E-07   *AC027309.2*   −8.141726   2.39E-07
  4       *AC108751.5*   8.748432         3.08E-06   *AC008021.1*   −8.061548   0.003452
  5       *AC010615.1*   8.698275         2.72E-07   *AC011444.3*   −7.130734   3.80E-07
  6       *AC121764.1*   8.650715         1.19E-06   *AC009093.4*   −6.598787   5.26E-06
  7       *AL138688.2*   8.633034         4.21E-07   *AL359771.1*   −6.485628   3.13E-06
  8       *MTCO1P21*     8.493677         2.92E-07   *AL109933.3*   −6.389374   9.01E-05
  9       *AL358234.1*   8.473512         5.91E-07   *AL121906.2*   −6.347108   5.36E-05
  10      *AC019117.2*   8.350703         1.60E-06   *AC019193.3*   −6.305771   3.27E-07
  Total   2344           1884                                                   

Abbreviation: FC, fold change

*P* \< 0.05 was considered statistically significant (asthenozoospermia vs. normal group).

To explore the potential functions of these DEGs, GO and KEGG pathway and DO enrichment analyses were applied with the down-regulated and up-regulated DEGs, separately. Through the GO analysis of DEGs, the up-regulated DEGs were found to be mostly enriched as follows: protein localization to endoplasmic reticulum and establishment of protein localization to membrane ribosome (BP), ribosome and ribosomal subunit (CC), channel activity and passive transmembrane transporter activity (MF) in the top 5 GO enriched terms ([Figure 3](#F3){ref-type="fig"}A and [Table 3](#T3){ref-type="table"}); the down-regulated DEGs were found to be mostly enriched as follows: nuclear division and organelle fission (BP), lateral element and P granule (CC) and nuclease activity and vitamin binding (MF) in the top 5 GO enriched terms ([Figure 3](#F3){ref-type="fig"}B and [Table 3](#T3){ref-type="table"}). KEGG pathway analysis revealed that the up-regulated DEGs were mainly associated with ribosome, transcriptional misregulation in cancer, alcoholism, cocaine addiction and ferroptosis in the top 10 KEGG pathways enriched ([Figure 3](#F3){ref-type="fig"}C and [Table 4](#T4){ref-type="table"}). In addition, the down-regulated DEGs exhibited a strong association with inflammatory and metabolism pathways, according to KEGG pathway analysis ([Figure 3](#F3){ref-type="fig"}D and [Table 4](#T4){ref-type="table"}). Through the DO analysis, we found that the up-regulated DEGs were significantly enriched among cancers ([Figure 3](#F3){ref-type="fig"}E and [Table 5](#T5){ref-type="table"}), while the down-regulated DEGs were associated with reproductive system disease, retinal degeneration and mycosis in the top 10 DO enriched ([Figure 3](#F3){ref-type="fig"}F and [Table 5](#T5){ref-type="table"}).

![Enrichment analyses of differentially expressed genes\
(**A** and **B**) Top 5 GO enriched terms for the up-regulated and down-regulated differentially expressed genes, respectively. (**C** and **D**) Top 10 KEGG pathways enriched for the up-regulated and down-regulated differentially expressed genes, respectively. (**E** and **F**) Top 10 DO enriched for the up-regulated and down-regulated differentially expressed genes, respectively; BP, biological process; CC, cellular component; FDR, false-discovery rate; MF, molecular function.](bsr-40-bsr20194041-g3){#F3}

###### GO enrichment analysis of up- and down-regulated DEGs (top 5)

  Ontology   Up-regulated DEGs   Down-regulated DEGs                                                                                                                                                                                                
  ---------- ------------------- --------------------------------------------------------------------------------------- ---- ---------- ------- ------------ --------------------------------------------------------------------- ---- ---------- ----------
  BP         GO:0000280          Nuclear division                                                                        48   1.63E-06   0.005   GO:0006614   SRP-dependent cotranslational protein targeting to membrane           25   1.19E-09   1.96E-06
             GO:0048285          Organelle fission                                                                       51   1.93E-06   0.005   GO:0070972   Protein localization to endoplasmic reticulum                         30   1.20E-09   1.96E-06
             GO:0140014          Mitotic nuclear division                                                                32   8.24E-05   0.135   GO:0072599   Establishment of protein localization to endoplasmic reticulum        27   1.31E-09   1.96E-06
             GO:0051321          Meiotic cell cycle                                                                      28   3.52E-04   0.330   GO:0090150   Establishment of protein localization to membrane                     48   1.90E-09   1.96E-06
             GO:0090305          Nucleic acid phosphodiester bond hydrolysis                                             31   4.21E-04   0.330   GO:0000184   Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay   27   1.94E-09   1.96E-06
  CC         GO:0000800          Lateral element                                                                         5    4.73E-04   0.293   GO:0022626   Cytosolic ribosome                                                    24   3.44E-08   2.18E-05
             GO:0043186          P granule                                                                               5    0.002      0.293   GO:0044391   Ribosomal subunit                                                     32   6.96E-08   2.21E-05
             GO:0045495          Pole plasm                                                                              5    0.002      0.293   GO:0005840   Ribosome                                                              38   1.19E-07   2.52E-05
             GO:0060293          Germ plasm                                                                              5    0.002      0.293   GO:0070382   Exocytic vesicle                                                      29   6.55E-06   0.001
             GO:0033391          Chromatoid body                                                                         4    0.005      0.469   GO:0008021   Synaptic vesicle                                                      26   2.73E-05   0.003
  MF         GO:0043015          Gamma-tubulin binding                                                                   7    0.001      0.259   GO:0003735   Structural constituent of ribosome                                    29   1.88E-06   0.002
             GO:0015926          Glucosidase activity                                                                    5    0.001      0.259   GO:0019843   rRNA binding                                                          12   0.001      0.215
             GO:0004518          Nuclease activity                                                                       23   0.001      0.355   GO:0022838   Substrate-specific channel activity                                   45   0.001      0.215
             GO:0016646          Oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor   5    0.002      0.438   GO:0015267   Channel activity                                                      46   0.002      0.215
             GO:0019842          Vitamin binding                                                                         17   0.003      0.438   GO:0022803   Passive transmembrane transporter activity                            46   0.002      0.215

Abbreviations: BP, biological process; CC, cellular component; DEG, differentially expressed gene; FDR, false-discovery rate; GO, Gene Ontology; MF, molecular function.

*P*\<0.05 was considered statistically significant.

###### KEGG pathway enrichment analysis of up- and down-regulated DEGs (top 10)

  Up-regulated DEGs   Down-regulated DEGs                                                                                                                  
  ------------------- ---------------------------------------- ---- ------- ------- ---------- ------------------------------------------- ---- ---------- ----------
  hsa00510            N-Glycan biosynthesis                    8    0.004   0.832   hsa03010   Ribosome                                    27   2.44E-07   7.09E-05
  hsa00830            Retinol metabolism                       9    0.007   0.832   hsa05030   Cocaine addiction                           9    0.003      0.378
  hsa03020            RNA polymerase                           5    0.015   0.832   hsa04970   Salivary secretion                          12   0.007      0.528
  hsa00760            Nicotinate and nicotinamide metabolism   5    0.017   0.832   hsa05031   Amphetamine addiction                       10   0.007      0.528
  hsa03460            Fanconi anemia pathway                   7    0.017   0.832   hsa05202   Transcriptional misregulation in cancer     19   0.017      0.968
  hsa05321            Inflammatory bowel disease               8    0.018   0.832   hsa04960   Aldosterone-regulated sodium reabsorption   6    0.024      0.999
  hsa05162            Measles                                  13   0.022   0.832   hsa04216   Ferroptosis                                 6    0.034      0.999
  hsa04657            IL-17 signaling pathway                  10   0.025   0.832   hsa05414   Dilated cardiomyopathy                      10   0.042      0.999
  hsa05222            Small cell lung cancer                   10   0.025   0.832   hsa05034   Alcoholism                                  17   0.044      0.999
  hsa00240            Pyrimidine metabolism                    7    0.030   0.900   hsa04137   Mitophagy - animal                          8    0.044      0.999

Abbreviations: DEG, differentially expressed genes; FDR, false-discovery rate; KEGG, Kyoto Encyclopedia of Genes and Genomes.

*P*\<0.05 was considered statistically significant.

###### DO enrichment analysis of up- and down-regulated DEGs (top 10)

  Up-regulated DEGs   Down-regulated DEGs                                                                                                                                
  ------------------- ------------------------------------------- ---- ------- ------- ------------ ------------------------------------------------------- ---- ------- -------
  DOID:15             Reproductive system disease                 36   0.000   0.148   DOID:11396   Pulmonary edema                                         4    0.005   1.000
  DOID:8466           Retinal degeneration                        26   0.001   0.148   DOID:3095    Germ cell and embryonal cancer                          5    0.005   1.000
  DOID:229            Female reproductive system disease          21   0.001   0.148   DOID:11119   Gilles de la Tourette syndrome                          4    0.012   1.000
  DOID:10871          Age-related macular degeneration            10   0.003   0.315   DOID:2769    Tic disorder                                            4    0.015   1.000
  DOID:2007           Degeneration of macula and posterior pole   10   0.003   0.315   DOID:1319    Brain cancer                                            7    0.020   1.000
  DOID:2473           Opportunistic mycosis                       7    0.003   0.315   DOID:10283   Prostate cancer                                         38   0.022   1.000
  DOID:4448           Macular degeneration                        10   0.003   0.333   DOID:2151    Malignant ovarian surface epithelial-stromal neoplasm   28   0.023   1.000
  DOID:0050136        Systemic mycosis                            7    0.004   0.373   DOID:2152    Ovary epithelial cancer                                 28   0.023   1.000
  DOID:0080008        Ischemic bone disease                       7    0.009   0.503   DOID:4001    Ovarian carcinoma                                       28   0.023   1.000
  DOID:1116           Pertussis                                   6    0.009   0.503   DOID:3307    Teratoma                                                3    0.025   1.000

Abbreviations: DEG, differentially expressed gene; DO, Disease Ontology; FDR, false-discovery rate.

*P*\<0.05 was considered statistically significant.

We compared the lncRNA and mRNA expression levels in the asthenozoospermia group with the normal group from the obtained RNA-sequencing data. In total, 995 DElncRNAs were obtained, including 656 up-regulated lncRNAs and 339 down-regulated lncRNAs in the asthenozoospermia compared with the normal control group (Supplementary Table S3). Top 10 significantly up-regulated and top 10 significantly down-regulated DElncRNAs were displayed in [Table 5](#T5){ref-type="table"}. The volcano plot and heatmaps for clustering analysis of DElncRNAs between asthenozoospermia and normal groups were displayed in [Figure 4](#F4){ref-type="fig"}A,B, respectively. To investigate possible lncRNA--mRNA interactions, we carried out RNA-sequencing analysis and revealed 2338 DEmRNAs between asthenozoospermia and normal control. Among these, 1128 mRNAs were up-regulated in asthenozoospermia group, whereas 1210 mRNAs were down-regulated (Supplementary Table S4). Top 10 significantly up-regulated and top 10 significantly down-regulated DEmRNAs (asthenozoospermia vs. normal) were displayed in [Table 5](#T5){ref-type="table"}. The volcano plot and heatmaps for clustering analysis of DEmRNAs between asthenozoospermia and normal groups were displayed in [Figure 4](#F4){ref-type="fig"}C,D, respectively. Moreover, we found 11,706 novel DElncRNAs (4321 up-regulated and 7385 down-regulated) in asthenozoospermia group compared with the normal group (Supplementary Table S5, [Table 6](#T6){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}E,F).

![Differentially expressed of lncRNAs and mRNAs between asthenozoospermia infertility and normal groups\
(**A** and **B**) Volcano plot and heatmap of DElncRNAs between asthenozoospermia infertility and normal groups. (**C** and **D**) Volcano plot and heatmap of DElmRNAs between asthenozoospermia infertility and normal groups. (**E** and **F**) Volcano plot and heatmap of novel DElmRNAs between asthenozoospermia infertility and normal groups. Black dots represent genes that are not significantly differentially expressed. Green and red dots indicate significant up-regulated and down-regulated genes (\|log 2 fold change\| ≥ 1.0 and *P* value ≤ 0.05), respectively. Row and column were used to represent DElncRNAs/DEmRNAs and samples. R: asthenozoospermia infertility; Z: normal. The color scale represented the expression levels of DElncRNAs/DEmRNAs.](bsr-40-bsr20194041-g4){#F4}

###### The differentially expressed lncRNAs, mRNAs and new lncRNAs (top 10)

                  Up-regulated   Down-regulated                                                            
  --------------- -------------- ---------------- ---------- ---------- -------------- -------- ---------- ----------
  lncRNAs         AC009965.1     9.768            2.61E-08   2.12E-04   AC011444.3     −7.131   3.80E-07   0.001
                  PCED1B-AS1     5.908            4.51E-07   0.001      AC019193.3     −6.306   3.27E-07   0.001
                  AL358234.1     8.474            5.91E-07   0.001      AC068389.1     −4.871   1.67E-06   0.002
                  AC121764.1     8.651            1.19E-06   0.001      AL359771.1     −6.486   3.13E-06   0.002
                  AC019117.2     8.351            1.60E-06   0.002      AC008735.2     −5.731   3.30E-06   0.002
                  AC112176.1     6.739            1.67E-06   0.002      AC009093.4     −6.599   5.26E-06   0.003
                  AC022398.1     7.654            5.01E-06   0.003      LINC02320      −5.486   1.10E-05   0.004
                  LSAMP-AS1      7.521            5.33E-06   0.003      AC022098.1     −4.276   1.67E-05   0.006
                  AC025300.1     7.738            6.08E-06   0.003      AC022098.2     −6.258   2.60E-05   0.007
                  LINC02042      6.713            6.91E-06   0.004      AL513320.1     −4.602   3.38E-05   0.008
  Total           656            339                                                                       
  mRNAs           *PIGC*         6.819            1.74E-07   0.001      *WFIKKN1*      −5.996   6.20E-08   2.16E-04
                  *C9orf72*      4.956            7.47E-07   0.001      *HES6*         −5.739   3.88E-08   2.16E-04
                  *PPP1R42*      7.797            1.09E-06   0.001      *RPLP2*        −5.240   1.46E-06   0.002
                  *KCTD4*        7.750            1.99E-06   0.002      *CRYAB*        −4.645   2.46E-06   0.002
                  *SYCP2*        4.721            8.74E-06   0.004      *TMEM178A*     −5.783   2.48E-06   0.002
                  *HORMAD1*      7.258            9.28E-06   0.004      *GOLGA6L1*     −5.864   3.15E-06   0.002
                  *PRDM5*        4.890            1.03E-05   0.004      *HMGN5*        −5.732   3.41E-06   0.002
                  *FRG2B*        7.209            1.55E-05   0.005      *OBP2B*        −4.662   4.11E-06   0.003
                  *TATDN1*       4.938            2.21E-05   0.007      *PSCA*         −5.078   5.01E-06   0.003
                  *HAPLN1*       4.435            2.66E-05   0.007      *NEFH*         −5.018   7.04E-06   0.004
  Total           1128           1210                                                                      
  Novel lncRNAs   MSTRG.187855   7.291            1.90E-08   2.34E-04   MSTRG.303611   −7.864   1.51E-08   2.34E-04
                  MSTRG.33224    11.060           2.11E-08   2.34E-04   MSTRG.84390    −9.343   1.67E-08   2.34E-04
                  MSTRG.160782   10.598           1.29E-07   0.001      MSTRG.179148   −7.059   2.49E-07   0.001
                  MSTRG.222091   10.538           1.20E-07   0.001      MSTRG.220024   −6.248   2.66E-07   0.001
                  MSTRG.282729   10.315           1.33E-07   0.001      MSTRG.200378   −7.405   2.99E-07   0.001
                  MSTRG.85233    9.884            1.05E-07   0.001      MSTRG.295090   −7.278   3.64E-07   0.001
                  MSTRG.313656   7.236            1.61E-07   0.001      MSTRG.112856   −6.166   6.75E-07   0.001
                  MSTRG.171336   10.708           1.96E-07   0.001      MSTRG.1639     −6.257   6.99E-07   0.001
                  MSTRG.261274   10.578           2.42E-07   0.001      MSTRG.167804   −6.459   8.44E-07   0.002
                  MSTRG.257433   10.073           3.11E-07   0.001      MSTRG.174054   −7.203   8.55E-07   0.002
  Total           4321           7385                                                                      

Abbreviations: FC, fold change; FDR, false-discovery rate.

*P*\<0.05 was considered statistically significant (asthenozoospermia vs. normal group).

To identify the correlation between DElncRNAs and DEmRNAs, we performed the Pearson's correlation test to calculate the correlation coefficients between lncRNA and mRNAs. The correlation coefficient was greater than 0.8 and *P* value less than 0.05 were defined as the DElncRNA--DEmRNA pairs coexpressed. We found 254,981 positive correlations DElncRNA--DEmRNA pairs. [Table 7](#T7){ref-type="table"} showed the top 10 positive correlations DElncRNA--DEmRNA pairs.

###### Association analysis of DELncRNAs and DEmRNAs (top 10)

  LncRNA        Coding gene   Correlation coefficient   *P*-value
  ------------- ------------- ------------------------- -----------
  AC080013.5    *APC2*        0.9996                    4.47E-09
  AC109495.1    *CCDC8*       0.9996                    5.63E-09
  AL138916.2    *ZFC3H1*      0.9996                    6.65E-09
  AC006116.9    *IL18R1*      0.9991                    5.31E-08
  AC005291.2    *ARG1*        0.9988                    1.01E-07
  AL132639.2    *ANGPTL7*     0.9984                    2.00E-07
  AL162497.1    *CDC26*       0.9982                    2.74E-07
  ARHGAP5-AS1   *ZBED6*       0.9980                    3.51E-07
  AL360270.2    *FAR1*        0.9980                    3.53E-07
  AL645728.1    *LAD1*        0.9980                    3.57E-07

Abbreviation: DE, differentially expressed

Correlation coefficient \>0.8 and *P*\<0.05 was considered statistically significant.

LncRNA functions by acting on protein-coding genes via cis-acting elements and trans-acting factors. In the present study, to explore how the DElncRNAs may alter sperm function. We predicted the cis- and trans-regulated target genes of DElncRNAs between asthenozoospermia and normal control groups. The closest coding genes to lncRNAs 100 kb upstream and downstream of them were screened, and their associations with lncRNA were analyzed using the Bedtools program. Seven cis-regulated correlation pairs lncRNA--mRNA (IGF2-AS/*IGF2*, AL139353.2/*HEATR5A*, AC003102.1/*UBTF*, AC010247.2/*POU2F2*, AC005034.3/*MRPL19*, AL031666.2/*ZMYND8*, and AFAP1-AS1/*AFAP1*), as showed in the [Table 8](#T8){ref-type="table"} and [Figure 5](#F5){ref-type="fig"}.

![Association of DElncRNAs and cis-regulated target genes\
The color represents the *P*-value of the correlation analysis. The size of the point represents the magnitude of the correlation coefficient. The horizontal axis is the distance between lncRNA and mRNA.](bsr-40-bsr20194041-g5){#F5}

###### The cis-regulated target genes of lncRNAs

  LncRNA       Gene        Chromosome   Distance   Correlation coefficient   *P*-value
  ------------ ----------- ------------ ---------- ------------------------- -----------
  IGF2-AS      *IGF2*      11           0          0.8613                    0.013
  AL139353.2   *HEATR5A*   14           −32301     0.9185                    0.003
  AC003102.1   *UBTF*      17           −2084      0.8036                    0.029
  AC010247.2   *POU2F2*    19           0          0.9086                    0.005
  AC005034.3   *MRPL19*    2            0          0.8355                    0.019
  AL031666.2   *ZMYND8*    20           0          0.8052                    0.029
  AFAP1-AS1    *AFAP1*     4            4624       0.8771                    0.010

Correlation coefficient \>0.8 and *P*\<0.05 was considered statistically significant.

We used DElncRNA--DEmRNA co-expression data combined with miRNA target relationship information in the starBase database to perform hypergeometric distribution tests to construct the lncRNA--miRNA--mRNA regulatory network ([Figure 6](#F6){ref-type="fig"}). The interaction network included 11 lncRNAs (LINC00893, AC005034.3, COX10-AS1, MIR497HG, LINC00894, AC015813.1, AP000424.1, MIR17HG, LINC00667, LINC00662 and SNHG3), 35 miRNAs and 59 mRNAs (Supplementary Table S6).

![lncRNA--miRNA--mRNA regulatory networks\
The red circle represents lncRNA, the blue triangle is the co-expressed gene, and the green pentagon represents the miRNA.](bsr-40-bsr20194041-g6){#F6}

To confirm the sequencing and bioinformatics results, two up-regulated (LINC00667 and COX10-AS1) and three down-regulated (LINC00893, MIR497HG and IGF2-AS) lncRNAs in asthenozoospermia group were chosen for qRT-PCR. Consistent with sequencing results, all five lncRNA were found to be differentially expressed in the asthenozoospermia group compared with the normal (*P*\<0.05; [Figure 7](#F7){ref-type="fig"}).

![qRT-PCR analysis of five lncRNAs expression between asthenozoospermia infertility and normal groups (\**P*\<0.05; \*\* *P*\<0.001)](bsr-40-bsr20194041-g7){#F7}

Discussion {#sec4}
==========

In the present study, we performed an RNA-sequencing analysis between asthenozoospermia and normal group and identified 4228 significantly DEGs (2344 up-regulated and 1884 down-regulated) in seminal plasma exosomes RNA. About 995 known DElncRNAs (656 up-regulated and 339 down-regulated) and 11,706 novel DElncRNAs (4321 up-regulated and 7385 down-regulated) and 2338 DEmRNAs (1128 up-regulated and 1210 down-regulated) were identified in the present study. We used the GO and KEGG pathway and DO enrichment analyses to further understand the potential biological functions of these DEGs. Moreover, the lncRNA--miRNA--mRNA co-expression network was constructed, and the result indicated that some hub lncRNAs and mRNAs were involved in asthenozoospermia. From the co-expression analyses, we identified seven cis regulated correlation pairs lncRNA--mRNA. In addition, five of the DElncRNAs were verified with qRT-PCR to further validate the reliability of the RNA-sequencing results.

Exosomes are 40--180 nm double membrane microvesicles originated from cell membrane, which thought to be involved in intercellular communication by transferring information via small biological molecules (i.e. lipids, proteins, DNA, mRNA and noncoding RNA) \[[@B21]\]. On the membrane surface of exosomes display several markers, including *CD9, CD63, CD81, LAMP1* and *TSG101* \[[@B21],[@B22]\]. We detect the antigen molecules *CD63* and *CD81* in the seminal plasma exosomes using the Western blot. The results indicated that *CD63* and *CD81* expressed in all samples, and the total protein content has no significant differences in asthenozoospermia group compared with the normal group. Previous studies indicated that semen exosomes affect spermatozoa motility and functions \[[@B7],[@B8]\].

LncRNAs can regulate gene expression and are abundant in the genomes of various organisms \[[@B23]\]. LncRNAs are usually more than 200 nucleotides in length and exhibit greater species, tissue, and cell specificity than do shorter-length microRNAs (miRNAs) and messenger RNAs (mRNAs) due to their evolutionary unconserved characteristics \[[@B24]\]. The main functions of lncRNAs include roles in chromatin modification, transcriptional regulation and post-transcriptional regulation. In addition, lncRNAs affect the regulation of mRNA translation and stability largely based on the competitive endogenous RNA (ceRNA) regulation mechanism of binding to miRNA. Increasing evidence indicated that the ceRNA regulatory network of lncRNA--miRNA--mRNA was important in different diseases \[[@B25],[@B26]\]. Accumulating evidence indicates that lncRNAs act as regulators in diverse biological processes and play important roles in many human diseases \[[@B27]\]. Moreover, several lncRNAs were reported to serve as disease biomarkers \[[@B28]\].

Recently, Zhang et al. \[[@B16]\] investigated the expression profiles and characteristics of lncRNAs in normal and asthenozoospermia sperm, and indicated the association between lncRNAs expression and sperm motility. In the present study, we performed an RNA-sequencing analysis of asthenozoospermia patients and normal controls seminal plasma exosomes and identified the DEGs, known DElncRNAs, DEmRNAs, the novel DElncRNAs, DEGs functions and involved pathway, and the ceRNA regulatory network of lncRNA--miRNA--mRNA. Seven cis regulated correlation pairs lncRNA--mRNA were identified in the present study.

Previous studies on the insulin-like growth factor II (IGF2) gene are the most widely reported. Spermatozoa is the only source of *IGF2* mRNA since *IGF2* is a paternally inherited gene. Poplinski et al. \[[@B29]\] conclude that low sperm counts were clearly associated with IGF2/H19 ICR1 hypomethylation, and idiopathic male infertility was strongly associated with imprinting defects at IGF2/H19 ICR1. Ni et al. \[[@B30]\] indicated that the aberrant methylation of *IGF2* and *KCNQ1* gene may be associated with sperm DNA damage. Tang et al. \[[@B31]\] revealed that miR-210 was involved in spermatogenesis by targeting *IGF2* in male infertility. Cannarella et al. \[[@B32]\] found that *IGF2* mRNA was found to be present in human spermatozoa, and their transcription levels were positively correlated with sperm concentration and total sperm count.

It has been reported that OCT2 (octamer binding protein 2, POU2F2) acts as a spermatogonial marker to distinguish the early stages of spermatogenesis \[[@B33]\]. *TLE3*, a transcriptional co-regulator that interacts with DNA-binding factors, plays a role in the development of somatic cells. Lee et al. \[[@B34]\] revealed that *TLE3* is differentially expressed in Sertoli cells and plays a crucial role in regulating cell-specific genes involved in the differentiation and formation of Sertoli cells during testicular development. Huang et al. \[[@B35]\] found that *MGAT1* was expressed at lower levels in mouse all germ-cell types, as well as somatic Sertoli cells. Previous studies showed that conditional deletion of the mouse Mgat1 gene (Mgat1 cKO) in spermatogonia causes a germ-cell autonomous defect leading to infertility, and *MGAT1* regulateed ERK1/2 signaling during spermatogenesis via different mechanisms \[[@B36],[@B37]\]. The loss of caseinolytic peptidase P (CLPP) leads to infertility in mice \[[@B38]\]. *EPB41* is one of the pleiotropic monogenic disorder\'s genes that cause male infertility, and manifests as azoospermia \[[@B39]\]. Bao et al. demonstrated that *LRRC8A*-dependent VRAC activity is essential for male germ cell development and fertility \[[@B40]\]. *LRRC8*/VRAC anion channels are required for late stages of spermatid development in mice \[[@B41]\].

In the present study, our results indicated that the *IGF2, POU2F2, TLE3, MGAT1, CLPP* and *LRRC8A* were co-expressed with lncRNAs IGF2-AS, AC010247.2, LINC00893, MIR497HG, MIR497HG and LINC00893, respectively. These mRNAs expression levels were down-regulated in the asthenozoospermia group compared with the normal group. The *EPB41* and *ODF2L* were co-expressed with lncRNAs LINC00667 and COX10-AS1, respectively. However, the two genes mRNAs expression levels were up-regulated in the asthenozoospermia group. Moreover, the qRT-PCR analysis confirmed our sequencing results. However, further studies are needed to evaluate the roles of DElncRNAs and DEmRNAs in the molecular mechanism of human asthenozoospermia.

There are some limitations that cannot be ignored in the present study. First, the study sample for RNAsequencing was relatively small, which limited the ability to determine the DElncRNA and DEmRNAs between asthenozoospermia and normal group. Further validation analysis with larger sample size and biological test was needed to confirm our conclusions. Second, the biological function study of significantly different lncRNA, mRNA and miRNA was not performed in our research. Therefore, the biological function analyses are required to provide improved understanding of the roles and mechanisms of DElncRNA and DEmRNAs in the pathogenesis of asthenozoospermia.

In conclusion, we identified key DElncRNA and DEmRNAs between asthenozoospermia and normal group. Furthermore, bioinformatics analysis identified the potential functions of DEgenes and the regulatory network was constructed. Our data provide a bioinformatics analysis of genes and pathways that may be involved in the pathological mechanisms of asthenozoospermia. However, further studies are still required to investigate their mechanisms in the occurrence and development of asthenozoospermia.
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